东诚药业：实控人由守谊所持196万股解除质押

Group 1 - The core business of Dongcheng Pharmaceutical is entirely focused on the biopharmaceutical industry, with a revenue composition of 100.0% from this sector for the year 2024 [1] Group 2 - Dongcheng Pharmaceutical announced on August 4 that its actual controller, You Shouyi, has lifted the pledge on part of the company's shares, specifically 1.96 million shares on August 1 [3] - As of August 4, 2025, You Shouyi holds approximately 103 million shares of Dongcheng Pharmaceutical, with a total of about 28.58 million shares pledged, representing 27.66% of the total shares held [3] - The overall risk associated with share pledges is considered manageable, and there is currently no risk of forced liquidation [3]